MULTIPLE MYELOMA. IV. ABNORMAL SERUM COMPONENTS AND BENCE JONES PROTEIN 1
Open Access
- 1 October 1951
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 30 (10), 1125-1142
- https://doi.org/10.1172/jci102533
Abstract
The abnormal serum and urinary proteins in 30 patients with multiple myeloma were studied, many as the disease activity was modified by urethane therapy, by methods including electro-phoresis, diffusion and ultracentrifugation.Keywords
This publication has 20 references indexed in Scilit:
- MULTIPLE MYELOMA. III. EFFECT OF URETHANE THERAPY ON PLASMA CELL GROWTH, ABNORMAL SERUM PROTEIN COMPONENTS AND BENCE JONES PROTEINURIA 1JCI Insight, 1950
- A STUDY OF RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMAThe American Journal of the Medical Sciences, 1950
- IMMUNOLOGICAL INVESTIGATIONS IN 10 CASES OF PLASMACYTOMA1950
- CRYOGLOBULINEMIA. I. REPORT OF TWO CASES WITH DISCUSSION OF CLINICAL MANIFESTATIONS, INCIDENCE AND SIGNIFICANCEAnnals of Internal Medicine, 1950
- A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMAJCI Insight, 1943
- BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA 1JCI Insight, 1943
- FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMAJCI Insight, 1941
- The serum proteins in multiple myelomatosisBiochemical Journal, 1940
- Immunological differences of crystalline Bence-Jones proteinsBiochemical Journal, 1940
- The behaviour of pathological sera in the ultracentrifugeBiochemical Journal, 1935